patients with cartilage defects

Bio & Pharma Volpara to supply breast cancer SW to US Defense Health Agency

Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...

Korean startups Near Brain gives hope to millions of stroke patients worldwide

Strokes are the second leading cause of death and the third leading cause of disabilities globally, according to the World Health Organization.To fi...

Artificial intelligence LG Innotek develops AI for raw material inspection

LG Innotek, a leading South Korean electronics parts maker, said on Wednesday it developed an artificial intelligence (AI) system that can filter ou...

North Korea A North Korean Diplomat Managed a Rare Defection: A Flight Out of Cuba

SEOUL—A North Korean diplomat posted in Cuba defected to South Korea with his family late last year, officials said this week, a rare esc...

Korean startups PhyxUp closes in on pre-seed round with US advance

PhyxUp Health Inc., an early stage South Korean digital healthcare startup, will soon close a pre-seed funding round, said its founder and chief, wh...

Tech, Media & Telecom LG CNS unveils PerfecTwin ERP Edition in US

South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., announced on Wednesday that it unveiled its testing solution PerfecTwin ...

Construction POSCO E&C develops solution for detecting wall cracks by drones

South Korea's POSCO E&C has developed a solution for apartment exterior wall maintenance using drones.The company announced on Tuesday that it h...

Artificial intelligence LG Innotek detects design flaws using AI tech

South Korean electronic parts manufacturer LG Innotek announced on Tuesday it has implemented an artificial intelligence (AI) analysis system to qui...

Bio & Pharma Celltrion Healthcare to supply Yuflyma to US pharmacy chain

South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...

Bio & Pharma Celltrion gets OK partial approval for phase 3 of biosimilar in Europe

South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...

Tech, Media & Telecom Naver to launch short-form service on portal’s front page

South Korea’s top online portal Naver Corp. said on Wednesday it is strengthening its short-form content service on surging demand for video c...

Bio & Pharma Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

Healthcare S.Korea to seek expansion of healthcare package export

South Korean government has set a goal to expand medical service exports by attracting 700,000 foreign patients and receiving 70 applications of ove...

COVID-19 Korea to lift most COVID-19 rules with lower crisis level

South Korean President Yoon Suk Yeol on Thursday declared an end to most COVID-19 restrictions including mandatory quarantine for patients of the pa...

Business & Politics S.Korea's medical tourists rebound to 50% of pre-pandemic levels

South Korea's medical tourism industry, which experienced a severe setback due to the COVID-19 pandemic, has shown considerable recovery, with the n...

Beauty & Cosmetics Botulinum toxin resistance emerges as key factor for safe use

As demand for botulinum toxin for aesthetic purposes is globally increasing, safe use of the drug has emerged as one of the most important issues in...

Bio & Pharma Welt gets second digital therapeutic device approval in S. Korea

South Korea's Ministry of Food and Drug Safety announced on Wednesday that it has approved the cognitive therapy software "WELT-I" developed by We...

Bio & Pharma AbClon shows promising results in clinical tests of leukemia treatment

South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...

Bio & Pharma Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer

South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...

Bio & Pharma AIMMED’s Somzz ushers in digital therapeutic device market in Korea

South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...

Bio & Pharma SK Biopharm holds sales meeting for marketing Cenobamate in US

On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...

Construction & Planning 10 villages featuring traditional Korean architecture to be built in Seoul

The Seoul Metropolitan Government is pursuing a "fusion Hanok" project of building 10 Hanok (traditional Korean architecture) villages in the capita...

Bio & Pharma HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China

South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...

Bio & Pharma Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect

Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...

Bio & Pharma GC Cell's AB-101 NK therapy achieves FDA fast-track status

South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...

Bio & Pharma Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan

South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...

Bio & Pharma Celltrion applies for EMA approval of smaller dose formulation of Yuflyma

Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...

Bio & Pharma SK Chemicals launches uremia itching treatment tablet

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...

Bio & Pharma Medipost's Cartistem shows effects on patellar cartilage defect patients

Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...

Bio & Pharma CJ applies to FDA for trials of immuno-anticancer drug candidate

CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...